Tranexamic acid reduces postbypass blood use: A double-blinded, prospective, randomized study of 210 patients

Annals of Thoracic Surgery

Volumn 61, Issue 4, 1996, Pages 1131-1135

  Katsaros, Demetrios ^a   Petricevic, Mark ^a   Snow, Norman J ^a   Woodhall, Dennis D ^a   Van Bergen, Robert ^a  

^a FAIRVIEW HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

AGED; ARTICLE; BLEEDING; BLOOD; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TIME;

AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIME FACTORS; TRANEXAMIC ACID;

EID: 0030117128     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00022-7     Document Type: Article

References (26)

1. Cosgrove DM III, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992;54:1031-8.
2. Verska JJ, Lonser ER, Brewer LA. Predisposing factors and management of hemorrhage following open-heart surgery. J Cardiovasc Surg 1972;13:361-8.
3. Kevy SV, Glickman RM, Bernhard WF, et al. The pathogenesis and control of the hemorrhagic defect in open heart surgery. Surg Gynecol Obstet 1966;123:313-8.
4. Fish KJ, Sarnquist FH, van Steennis C, et al. A prospective randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. J Thorac Cardiovas Surg 1986;91:436-42.
5. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double-blind randomized trial. N Engl J Med 1986;314:1402-6.
6. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70.
7. Lemmer JH, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994;107:543-53.
8. Daily PO, Lamphere JA, Dembitsky WP, et al. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blinded study. J Thorac Cardiovasc Surg 1994;108:99-105.
9. Nakashima A, Matsuzaki K, Fukumura F, et al. Tranexamic acid reduces blood loss after cardiopulmonary bypass. ASAIO Trans 1993;39:185-9.
10. Horrow JC, Hlavacek J, Strong MD, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. Thorac Cardiovasc Surg 1990;99:70-4.
11. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology 1995;82:383-92.
12. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 1992;39:353-65.
13. Fricke W, Alling D, Kimball J, Griffith P, Klein H. Lack of efficacy of tranexamic acid in thrombocytopenic bleeding. Transfusion 1991;31:345-8.
14. Ovrum E, Holen EA, Abdelnoor M, et al. Tranexamic acid (cyclocapron) is not necessary to reduce blood loss after coronary bypass operations. J Thorac Cardiovasc Surg 1993; 105:78-83.
15. Kukuk O, Kwaan HC, Frederickson J, Wade L, Green D. Increased fibrinolysis in patients undergoing cardiopulmonary bypass operation. Am J Hematol 1986;23:223-9.
16. Hashim SW, Kay HR, Hammond GL, Kopf GS, Geha AS. Noncardiogenic pulmonary edema after cardiopulmonary bypass: an anaphylactic reaction to fresh frozen plasma. Am J Surg 1984;147:560-4.
17. Murphy PJ, Connery C, Hicks GL, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary bypass graft operations. J Thorac Cardiovasc Surg 1992;104:1092-9.
18. Foster RS, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985;55:1195-201.
19. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991;38:113-9.
20. Plotz FB, van Oeveren W, Aloe LS, et al. Prophylactic administration of tranexamic acid preserves platelet numbers during extracorporeal circulation in rabbits. ASAIO Trans 1991;37:M416-7.
21. Davies D, Howell DA. Tranexamic acid and arterial thrombosis [Letter]. Lancet 1977;1:49.
22. Rydin E, Lundberg PO. Tranexamic acid and intracranial thrombosis [Letter]. Lancet 1976;2:49.
23. Parsons MR, Merritt DR, Ramsay RC. Retinal artery occlusion associated with tranexamic acid. Am J Opth 1988;105: 688-9.
24. Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985;290:1453-56.
25. Bekassy A, Astedt B. Treatment with the fibrinolytic inhibitor tranexamic acid - risk for thrombosis? Acta Obstet Gynecol Scand 1990;69:353-4.
26. Astedt B, Liedholm P, Wingerup L. The effect of tranexamic acid on the fibrinolytic activity of vein walls. Ann Chir Gynecol 1978;67:203-5.